Biohaven (BHVN) Current Assets (2021 - 2026)
Biohaven (BHVN) reported Current Assets of $385.6 million for Q1 2026, up 0.76% on a YoY basis from $382.8 million in Q1 2025, and up 4.7% sequentially from $368.3 million in Q4 2025.
Biohaven (BHVN) Current Assets (2021 - 2026) Analysis & Trends
Biohaven (BHVN) has 6 years of Current Assets data on file, last reported at $385.6 million in Q1 2026.
- For the quarter ending Q1 2026, Current Assets rose 0.76% year-over-year to $385.6 million; the trailing twelve-month figure through Mar 2026 stood at $385.6 million (up 0.76% YoY), and the FY2025 full-year result was $368.3 million, down 31.6% from the prior year.
- Current Assets grew to $385.6 million in Q1 2026, from $368.3 million in the prior quarter.
- In the past five years, Current Assets ranged from a high of $587.0 million in Q4 2022 to a low of $80.6 million in Q3 2022.
- A 5-year average of $411.6 million and a median of $434.1 million in 2023 frame the typical range for Current Assets.
- Across the five-year window, Current Assets soared 519.01% in 2022 and plunged 35.95% in 2024, its largest moves.
- Tracing BHVN's Current Assets over 5 years: stood at $587.0 million in 2022, then decreased by 24.62% to $442.4 million in 2023, then gained by 21.7% to $538.5 million in 2024, then sank by 31.6% to $368.3 million in 2025, then gained by 4.7% to $385.6 million in 2026.
- Business Quant data shows BHVN's Current Assets at $385.6 million in Q1 2026, $368.3 million in Q4 2025, and $323.6 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 289.93 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | 73.04 Mn |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 6.60 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | 35.73 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 11.73 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 18.21 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | 521.86 Mn |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 8.07 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 1.97 Bn |
| 10 | Biohaven | 2.16 Bn | 1.81 Bn | - | 385.65 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 385.65 Mn |
| Dec 31, 2025 | 368.33 Mn |
| Sep 30, 2025 | 323.62 Mn |
| Jun 30, 2025 | 474.83 Mn |
| Mar 31, 2025 | 382.76 Mn |
| Dec 31, 2024 | 538.47 Mn |
| Sep 30, 2024 | 440.50 Mn |
| Jun 30, 2024 | 511.27 Mn |
| Mar 31, 2024 | 348.74 Mn |
| Dec 31, 2023 | 442.45 Mn |
| Sep 30, 2023 | 310.57 Mn |
| Jun 30, 2023 | 434.12 Mn |
| Mar 31, 2023 | 544.48 Mn |
| Dec 31, 2022 | 586.97 Mn |
| Sep 30, 2022 | 80.55 Mn |
| Dec 31, 2021 | 94.82 Mn |